Oral News and Research

RSS

Genentech submits NDA to FDA for vismodegib to treat advanced basal cell carcinoma

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that its collaborator Genentech, a member of the Roche Group, has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking sales and marketing approval for vismodegib to treat people with advanced basal cell carcinoma (BCC), which includes metastatic and locally advanced BCC for whom surgery is inappropriate.

12 Sep 2011

Genentech submits vismodegib NDA to FDA for treatment of advanced basal cell carcinoma

Genentech, a member of the Roche Group, today announced that the company has submitted a New Drug Application for vismodegib to the U.S. Food and Drug Administration (FDA) for the treatment of people with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate.

12 Sep 2011

Spinifex announces new data from EMA401 pre-clinical study on diabetic neuropathy

Spinifex Pharmaceuticals, an Australian pain drug development company, today announces the presentation of new data from a study of EMA401 in a model of diabetic neuropathy.

12 Sep 2011

Gay blood donations to be allowed soon in UK

Soon the lifetime ban on blood donations by homosexual and bisexual men will be lifted in England, Scotland and Wales. Ministers have agreed to let men who have not had sex with another man in the past 12 months to donate from November.

12 Sep 2011

Preterm babies may be experiencing pain during procedures: Study

Preterm may begin to feel pain around a woman's 35th week of pregnancy, about two to four weeks before delivery, according to a new study from University College London. Using EEG, researchers recorded the babies' brain activity in response to pain, comparing their pain responses from a touch and prick on the heels. The findings were published in the journal Current Biology.

9 Sep 2011

Researchers create powerful anti-diabetic prototype drugs with lesser side effects

Researchers from Dana-Farber Cancer Institute in Boston and the Scripps Research Institute in Jupiter, Fla., report they have created prototype drugs having powerful anti-diabetic effects, yet apparently free - at least in mice - of dangerous side effects plaguing some current diabetes medications.

9 Sep 2011

Health law gains win as court blocks two legal challenges

The 4th Circuit Court of Appeals issued two opinions yesterday in which it concluded that neither the Commonwealth of Virginia nor Liberty University had legal standing to sue the government in an attempt to block the health law's individual mandate.

9 Sep 2011

State roundup: Calif. hospitals fined for errors; Va. dental health concerns

Grady Memorial Hospital and Fresenius Medical Care have reached a basic agreement on providing dialysis services for 22 immigrants whose regular treatment ended last week. The Grady spokesman, Matt Gove, said that under the new deal, Grady will help cover the cost of dialysis for the patients, who up until two years ago were regularly treated at the hospital's outpatient facility.

9 Sep 2011

Cardiovascular and Renal Drugs Advisory Committee recommends FDA approval of J&JPRD's rivaroxaban

Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD) announced today that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee recommended approval of rivaroxaban, a novel, once-daily, oral anticoagulant, for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.

9 Sep 2011

Sagene completes SPI-1972 pre-IND meeting with FDA for erectile dysfunction

Sagene Pharmaceuticals, Inc., a biopharmaceutical company focused on developing combinations of FDA-approved drugs to treat diseases associated with aging, has completed a pre-IND meeting with the Division of Reproductive and Urologic Products of the FDA to discuss the development plan for SPI-1972, a dual-action combination treatment for erectile dysfunction.

9 Sep 2011

First Edition: September 8, 2011

In today's headlines, reports from last night's GOP presidential debate, as well as explorations of what the future might hold for the 'Super Committee' and news developments related to physician payment issues.

8 Sep 2011

Study: Almost one third of students in Uganda have been subject to sexual coercion

Almost one third of students at a university in Uganda say that they have been subject to sexual coercion, an experience which was often linked to risky sexual behaviour. This is shown in a study from Lund University in Sweden.

8 Sep 2011

ATA announces five recipients of 2011 thyroid cancer research grants

The American Thyroid Association (ATA) announced the five recipients of its 2011 research grants, each of whom will receive up to $25,000 annually for up to two years. Three of the five recipients were awarded special ATA ThyCa grants for research projects that focus on thyroid cancer. These grants are funded by ThyCa: Thyroid Cancer Survivors, Inc.

8 Sep 2011

Lilly, Boehringer Ingelheim to present latest data from diabetes portfolio at 47th EASD meeting

Boehringer Ingelheim and Eli Lilly and Company will present the latest data from their diabetes portfolio at the 47th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Lisbon, Portugal, September 12-16.

8 Sep 2011

GE Healthcare granted exclusive distribution rights to KC BioMedix NTrainer neurostimulation system

GE Healthcare, Inc. and KC BioMedix, Inc. today announced an agreement that grants GE Healthcare's Maternal Infant Care division exclusive rights for distribution and marketing of the KC BioMedix NTrainer pulsatile neurostimulation system.

8 Sep 2011

Innovative approach improves feeding outcomes among infants

An innovative approach to treating neonatal feeding problems at Nationwide Children's Hospital has allowed infants who were struggling to feed orally to be discharged earlier and without feeding tubes, subsequently saving millions of annual healthcare charges.

8 Sep 2011

Hi-Tech Pharmacal first quarter sales increase 43% to $56.2 million

Hi-Tech Pharmacal Co., Inc. today reported results for the Company's fiscal first quarter ended July 31, 2011.

7 Sep 2011

Researchers rethink fenretinide for prevention of oral cancer

Scientists on the cutting edge of biomedical research know that research is a process - a combination of successes and failures that inform the next step forward. However, for some researchers at The Ohio State University progress means taking a step back. Supported by the Ohio State University Center for Clinical and Translational Science (CCTS), these scientists are using failed and forgotten research to uncover future treatments for major health conditions as diverse as oral cancer and stroke.

7 Sep 2011

The ABCs of proper brushing

For kids, brushing their teeth isn't always top of mind, and getting them to brush properly can be a real challenge for parents. But getting back into daily school routines is a great time to make sure kids are brushing often - and properly.

7 Sep 2011

Ohio man dies from tooth infection after he couldn't afford medicine

A 24-year-old Cincinnati father died from a tooth infection this week because he couldn't afford his medication, offering a sobering reminder of the importance of oral health and the number of people without access to dental or health care. According to NBC affiliate WLWT, Kyle Willis' wisdom tooth started hurting two weeks ago. When dentists told him it needed to be pulled, he decided to forgo the procedure, because he was unemployed and had no health insurance.

7 Sep 2011

Oral News and Research

Genentech submits NDA to FDA for vismodegib to treat advanced basal cell carcinoma

Genentech submits vismodegib NDA to FDA for treatment of advanced basal cell carcinoma

Spinifex announces new data from EMA401 pre-clinical study on diabetic neuropathy

Gay blood donations to be allowed soon in UK

Preterm babies may be experiencing pain during procedures: Study

Researchers create powerful anti-diabetic prototype drugs with lesser side effects

Health law gains win as court blocks two legal challenges

State roundup: Calif. hospitals fined for errors; Va. dental health concerns

Cardiovascular and Renal Drugs Advisory Committee recommends FDA approval of J&JPRD's rivaroxaban

Sagene completes SPI-1972 pre-IND meeting with FDA for erectile dysfunction

First Edition: September 8, 2011

Study: Almost one third of students in Uganda have been subject to sexual coercion

ATA announces five recipients of 2011 thyroid cancer research grants

Lilly, Boehringer Ingelheim to present latest data from diabetes portfolio at 47th EASD meeting

GE Healthcare granted exclusive distribution rights to KC BioMedix NTrainer neurostimulation system

Innovative approach improves feeding outcomes among infants

Hi-Tech Pharmacal first quarter sales increase 43% to $56.2 million

Researchers rethink fenretinide for prevention of oral cancer

The ABCs of proper brushing

Ohio man dies from tooth infection after he couldn't afford medicine

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News